Targeting CSK kinase activity to enhance antitumor immunity

被引：0
|
作者：
Wang, Cindy [1 ]
Cao, Carolyn [1 ]
Berman-Booty, Lisa [1 ]
Swanson, Jesse [1 ]
Eraslan, Rukiye [1 ]
Sanjuan, Miguel [1 ]
Vite, Gregory [1 ]
Qin, Lan-Ying [1 ]
Hunt, John [1 ]
Fink, Brian [1 ]
Wee, Susan [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B198
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B198
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Multifunctional Nanomodulators Regulate Multiple Pathways To Enhance Antitumor Immunity
    Zheng, Yadan
    Zhang, Zhanzhan
    Liu, Qi
    Zhao, Yu
    Zheng, Chunxiong
    Hao, Jialei
    Yi, Kaikai
    Wang, Ying
    Wang, Chun
    Zhao, Xinzhi
    Shi, Linqi
    Kang, Chunsheng
    Liu, Yang
    ACS APPLIED BIO MATERIALS, 2020, 3 (07): : 4635 - 4642
  • [32] IL-2 TRANSDUCED FIBROBLASTS ENHANCE ANTITUMOR IMMUNITY
    FAKHRAI, H
    SHAWLER, D
    GJERSET, R
    NAVIAUX, R
    SOBOL, R
    ROYSTON, I
    FASEB JOURNAL, 1992, 6 (04): : A1404 - A1404
  • [33] TUMOR ANTIGENS CAN BE COVALENTLY CROSSLINKED TO ENHANCE ANTITUMOR IMMUNITY
    Wang, Yanping
    Wang, Xiang-Yang
    Subjeck, John
    Kim, Hyung
    JOURNAL OF UROLOGY, 2011, 185 (04): : E98 - E98
  • [34] A clinically useful approach to enhance immunological memory and antitumor immunity
    Berezhnoy, Alex
    Rajagopalan, Anugraha
    Gilboa, Eli
    ONCOIMMUNOLOGY, 2014, 3 (05)
  • [35] DC-recruiting biomaterial vaccine to enhance antitumor immunity
    Li, Aileen W.
    Dellacherie, Maxence O.
    Sobral, Miguel
    Ali, Omr O.
    Kim, Jaeyun
    Mooney, David J.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [36] Development of a RIPK1 degrader to enhance antitumor immunity
    Yu, Xin
    Lu, Dong
    Qi, Xiaoli
    Paudel, Rishi Ram
    Lin, Hanfeng
    Holloman, Bryan L.
    Jin, Feng
    Xu, Longyong
    Ding, Lang
    Peng, Weiyi
    Wang, Meng C.
    Chen, Xi
    Wang, Jin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [37] Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders
    Bochtler, T.
    Kirsch, M.
    Maier, B.
    Bachmann, J.
    Klingmueller, U.
    Anderhub, S.
    Ho, A. D.
    Kraemer, A.
    LEUKEMIA, 2012, 26 (04) : 728 - 735
  • [38] Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders
    T Bochtler
    M Kirsch
    B Maier
    J Bachmann
    U Klingmüller
    S Anderhub
    A D Ho
    A Krämer
    Leukemia, 2012, 26 : 728 - 735
  • [39] Targeting Innate Immunity to Enhance the Efficacy of Radiation Therapy
    Dar, Tahir B.
    Henson, Regina M.
    Shiao, Stephen L.
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [40] pH-Triggered Surface Charge Reversed Nanoparticle with Active Targeting To Enhance the Antitumor Activity of Doxorubicin
    Du, Jiang-bo
    Cheng, Ying
    Teng, Zeng-hui
    Huan, Meng-lei
    Liu, Miao
    Cui, Han
    Zhang, Bang-le
    Zhou, Si-yuan
    MOLECULAR PHARMACEUTICS, 2016, 13 (05) : 1711 - 1722
12345